Compare 10X Genomics Inc (TXG) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Waste Management, Inc. — how do they compare? 10X Genomics Inc trades at $79 (market cap $10.07B), while Waste Management, Inc. trades at $209.89 (market cap $83.98B). The key difference: Waste Management, Inc. is far larger — about 8.3× 10X Genomics Inc's market cap, and Waste Management, Inc. pays a 1.8% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold 10X Genomics Inc for 92 Days and Waste Management, Inc. for 130 Days on average.
| TXG | WM | |
|---|---|---|
Market Cap | $10.07B | $83.98B |
Volume | 5,657,286 | 2,182,180 |
Sector | Health | Industrials |
52-Week High | $97.74 | $246.51 |
52-Week Low | $11.48 | $196.77 |
Typical Hold Time | 92 Days | 130 Days |
Enterprise Value | $9.59B | $106.78B |
Dividend Yield | — | 1.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
10x Genomics (TXG) trades at $76.10, down 5.65% on the day, as technical indicators signal bearish momentum with the stock below key resistance levels. The company shows improving fundamentals with three consecutive quarterly earnings beats and positive operating cash flow of $136M in 2025, though it remains unprofitable with a -12.18% net margin. Recent developments include the launch of Atera spatial biology platform shipments and a patent victory against Parse Biosciences.
TXG presents a mixed investment case with strong product innovation and improving financial trends offset by high valuation metrics and persistent losses. The stock's risk/reward appears balanced near analyst consensus targets, requiring successful execution on Atera commercialization and path to profitability to justify current multiples.
Waste Management (WM) trades at $208.94, up 0.51% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates strong fundamentals with $25.2B revenue in 2025, 11.12% net margin, and consistent earnings beats in recent quarters. Recent news highlights WM's defensive business model and dividend reliability, while analyst consensus remains strongly positive with 57% buy ratings.
WM presents a compelling long-term investment with stable cash flows and dividend growth potential, though elevated debt levels and near-term technical weakness warrant caution. The stock's premium valuation (P/E 29.55) reflects quality but limits near-term upside absent significant earnings acceleration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
